Mereo BioPharma Group plc (MREO)

CIK 1719714 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Mereo BioPharma Group plc.

Recent SEC filings

FiledFormAccession number
Aug 19, 20268-K0001193125-26-356168
Aug 14, 2026SCHEDULE 13G/A0000935836-26-000413
Aug 11, 20268-K0001193125-26-343519
Aug 11, 20268-K0001193125-26-343482
Aug 11, 202610-Q0001193125-26-343533
May 15, 2026SCHEDULE 13G/A0000935836-26-000265
May 14, 2026SCHEDULE 13G0000070858-26-000293
May 14, 20268-K0001193125-26-223071
May 12, 20268-K0001193125-26-218192
May 12, 202610-Q0001193125-26-218232
May 12, 20268-K/A0001193125-26-218290
Apr 9, 2026ARS0001193125-26-148835
Apr 9, 2026DEF 14A0001193125-26-148832
Mar 27, 2026PRE 14A0001193125-26-127271
Mar 27, 20268-K0001193125-26-127253
Mar 19, 20268-K0001193125-26-115211
Mar 19, 202610-K0001193125-26-115226
Feb 27, 202640001193125-26-082818
Feb 27, 202640001193125-26-082820
Feb 27, 202640001193125-26-082831
Feb 27, 202640001193125-26-082830
Feb 27, 202640001193125-26-082835
Feb 27, 202640001193125-26-082815
Feb 27, 202640001193125-26-082838
Feb 27, 202640001193125-26-082826